Skip to Content

Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)

Levemir is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).

Posted: June 2005

Related Articles:

Levemir (insulin detemir ) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.